TAPINAROF CREAM IMPROVED ITCH IN TWO PHASE 3 TRIALS OF MODERATE TO SEVERE ATOPIC DERMATITIS

被引：0
|
作者：
Silverberg, J.
Boguniewicz, M.
Rubenstein, D.
Tallman, A.
Brown, P.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P282
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [21] Improved quality of life in patients treated with lebrikizumab monotherapy is mediated by improvements in itch and sleep: results from two phase III trials in patients with moderate-to-severe atopic dermatitis
    Yosipovitch, Gil
    de Bruin-Weller, Marjolein
    Wiseman, Marni
    Elberling, Jesper
    Gutermuth, Jan
    Pierce, Evangeline
    Montmayeur, Sonia
    Yang, Fan Emily
    Ding, Yuxin
    Bardolet, Laia
    Chisolm, Sarah
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2025,
  • [22] Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age
    Silverberg, Jonathan, I
    Eichenfield, Lawrence F.
    Hebert, Adelaide A.
    Simpson, Eric
    Gold, Linda Stein
    Bissonnette, Robert
    Papp, Kim A.
    Browning, John
    Kwong, Pearl
    Korman, Neil J.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Somerville, Matthew C.
    Tallman, Anna M.
    Kircik, Leon
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II17 - II18
  • [23] Effect of upadacitinib on atopic hand eczema in patients with moderate-to-severe atopic dermatitis: Results from two randomized phase 3 trials
    Simpson, E. L.
    Rahawi, K.
    Hu, X.
    Chu, A. D.
    Nduaka, C.
    Jazayeri, S.
    Lio, P.
    Lynde, C.
    Schuttelaar, M. L. A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, : 1863 - 1870
  • [24] Dupilumab in moderate-to-severe atopic dermatitis: results from two randomized phase 3 trials (SOLO 1 & 2)
    Simpson, E. L.
    Bieber, T.
    Guttman-Yassky, E.
    Beck, L. A.
    Blauvelt, A.
    Cork, M. J.
    Silverberg, J. I.
    Deleuran, M.
    Kataoka, Y.
    Lacour, J. -P.
    Kingo, K.
    Worm, M.
    Poulin, Y.
    Wollenberg, A.
    Soo, Y.
    Graham, N. M. H.
    Pirozzi, G.
    Akinlade, B.
    Staudinger, H.
    Mastey, V.
    Eckert, L.
    Gadkari, A.
    Ardeleanu, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 79 - 79
  • [25] Efficacy of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis by age of onset: analysis of two phase 3 clinical trials
    Zirwas, Matthew J.
    Boguniewicz, Mark
    Rosmarin, David
    Fuxench, Zelma Chiesa
    Warren, Richard B.
    Torres, Tiago
    de Bruin-Weller, Marjolein
    Dawson, Zach
    Atwater, Amber Reck
    Elmaraghy, Hany
    Pierce, Evangeline
    Bardolet, Laia
    Zhong, Jinglin
    Armstrong, April W.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 54 - 56
  • [26] EFFICACY AND SAFETY OF ROFLUMILAST CREAM 0.15% IN ADULTS AND CHILDREN AGED 6 AND OLDER WITH MILD TO MODERATE ATOPIC DERMATITIS IN TWO PHASE 3 INTEGUMENT TRIALS
    Simpson, E.
    Eichenfield, L. F.
    Gooderham, M.
    Gonzalez, M.
    Hebert, A. A.
    Papp, K. A.
    Prajapati, V
    Krupa, D.
    Burnett, P.
    Berk, D. R.
    Higham, R.
    VALUE IN HEALTH, 2023, 26 (06) : S40 - S40
  • [27] Dupilumab Treatment Rapidly Improves Itch in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Chao, Jingdong
    Eckert, Laurent
    Chen, Zhen
    Ardeleanu, Marius
    Shumel, Brad
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Gadkari, Abhijit
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 29 - 29
  • [28] DUPILUMAB TREATMENT RAPIDLY IMPROVES ITCH IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Silverberg, J.
    Chao, J.
    Eckert, L.
    Chen, Z.
    Ardeleanu, M.
    Shumel, B.
    Plaum, S.
    Graham, N.
    Pirozzi, G.
    Gadkari, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S95 - S95
  • [29] Onset and Long-Term Maintenance of Optimal Itch Response in Adult Patients with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab: Post Hoc Analysis from Two Phase 3 Trials
    Staender, Sonja
    Yosipovitch, Gil
    Simpson, Eric L.
    Kim, Brian S.
    Kabashima, Kenji
    Thaci, Diamant
    Metz, Martin
    Chen, Zhen
    Hagen, Sandra
    Bastian, Mike
    ADVANCES IN THERAPY, 2025, : 1800 - 1810
  • [30] Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 Weeks
    Paller, Amy S.
    Mendes-Bastos, Pedro
    Siegfried, Elaine
    Eichenfield, Lawrence F.
    Soong, Weily
    Prajapati, Vimal H.
    Lio, Peter
    Simpson, Eric L.
    Raymundo, Eliza M.
    Suravaram, Smitha
    Hu, Xiaofei
    Yang, Yang
    Huang, Xiaohong
    Calimlim, Brian M.
    Platt, Andrew M.
    Su, John C.
    Zheng, Min
    Yamamoto-Hanada, Kiwako
    Teixeira, Henrique D.
    Irvine, Alan D.
    JAMA DERMATOLOGY, 2024, 160 (12) : 1304 - 1313
12345